Stryker, Boston Scientific tie-up could create ‘higher growth Medtronic’

Analysts are eagerly digging into the news that Stryker (NYSE:SYK) put in a takeover bid with Boston Scientific (NYSE:BSX), though many were surprised by the news and are unsure of the obvious strategic value of the acquisition.

News of the deal, which both companies have officially responded to with statemens of “no comment,” emerged yesterday at the Wall Street Journal.

The merger could create a “higher growth Medtronic,” according to Evercore’s Vijay Kumar, adding approximately 2% to Stryker’s expected 2019 earnings per share and up to 6% by next year, SeekingAlpha reported.

Get the full story on our sister site MassDevice.

Don't Miss the Most Anticipated Conference of the Fall! DeviceTalks Boston is just a few months away. More than 50 speakers and 35 exhibitors will join over 400 members of this red-hot industry, for a look inside the most important developments facing our community. Join us for three days of world-class education, networking, and a technology exhibition featuring the leading companies in the industry. Take a look at our speaker line-up and more.